Werewolf Therapeutics, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1287881,
    "name": "Werewolf Therapeutics, Inc.",
    "stock_name": "Werewolf Therapeutics, Inc.",
    "full_name": "Werewolf Therapeutics, Inc.",
    "name_url": "stocks-analysis/werewolf-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.00",
    "chg": 0.14,
    "chgp": "15.85%",
    "dir": 1,
    "prev_price": "0.86",
    "mcapval": "60.82",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US95075A1079",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.18 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/werewolf-therapeutics-inc-1287881-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Werewolf Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-werewolf-therapeutics-inc-technically-bullish-or-bearish-3548051",
        "imagepath": "",
        "date": "2025-09-20 20:08:41",
        "description": "As of 11 September 2025, the technical trend for Werewolf Therapeutics, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly KST is bearish, and the Bollinger Bands show a mildly bearish signal on that same timeframe. The Dow Theory indicates a mildly bullish trend on the weekly chart, while the OBV is mildly bullish on the weekly but mildly bearish on the monthly.\n\nIn terms of performance, the stock has returned 9.02% over the past month, significantly outperforming the S&P 500's 2.33% return in the same period. However, the year-to-date return is -2.03%, lagging behind the S&P 500's 12.22%. Overall, the current technical stance is mildly bullish, driven by positive signals from the MACD and moving averages, despite some mixed indicators in other metrics...."
      },
      {
        "title": "Is Werewolf Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-werewolf-therapeutics-inc-overvalued-or-undervalued-3544224",
        "imagepath": "",
        "date": "2025-09-20 18:40:58",
        "description": "As of 14 August 2025, the valuation grade for Werewolf Therapeutics, Inc. has moved from risky to does not qualify, indicating a deterioration in its investment appeal. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 1.11 and an EV to Capital Employed of just 0.05, which suggest that the market may be pricing in more value than the company can deliver. Additionally, the ROCE stands at an impressive 1104.53%, but this is overshadowed by a negative ROE of -127.93%, highlighting significant financial challenges.\n\nIn comparison to its peers, Chimerix, Inc. has a P/E ratio of -8.6897, while CytomX Therapeutics, Inc. stands out as very attractive with a P/E of 7.4924. This suggests that Werewolf Therapeutics is not only lagging behind its competitors but also struggling to establish a solid valuation framework. Over the past year, the stock has returned -..."
      }
    ],
    "total": 6,
    "sid": "1287881",
    "stock_news_url": "https://www.marketsmojo.com/news/werewolf-therapeutics-inc-1287881"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Werewolf Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:08:41

As of 11 September 2025, the technical trend for Werewolf Therapeutics, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly KST is bearish, and the Bollinger Bands show a mildly bearish signal on that same timeframe. The Dow Theory indicates a mildly bullish trend on the weekly chart, while the OBV is mildly bullish on the weekly but mildly bearish on the monthly. In terms of performance, the stock has returned 9.02% over the past month, significantly outperforming the S&P 500's 2.33% return in the same period. However, the year-to-date return is -2.03%, lagging behind the S&P 500's 12.22%. Overall, the current technical stance is mildly bullish, driven by positive signals from the MACD and moving averages, despite some mixed indicators in other metrics....

Is Werewolf Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:40:58

As of 14 August 2025, the valuation grade for Werewolf Therapeutics, Inc. has moved from risky to does not qualify, indicating a deterioration in its investment appeal. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 1.11 and an EV to Capital Employed of just 0.05, which suggest that the market may be pricing in more value than the company can deliver. Additionally, the ROCE stands at an impressive 1104.53%, but this is overshadowed by a negative ROE of -127.93%, highlighting significant financial challenges. In comparison to its peers, Chimerix, Inc. has a P/E ratio of -8.6897, while CytomX Therapeutics, Inc. stands out as very attractive with a P/E of 7.4924. This suggests that Werewolf Therapeutics is not only lagging behind its competitors but also struggling to establish a solid valuation framework. Over the past year, the stock has returned -...

View All News